[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6591 

# __Use of unapproved drugs for covid-19 treatment__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Conduct rigorous clinical trials and regulatory approval processes for drugs](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8465.md)

## Name of the risk

Uncertain effectiveness and potential risks to patients

## People affected by this risk

* [Patients with covid-19](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5550.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies and regulatory authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5551.md)

## Technologies linked to the risk

* [Clinical trial management systems and drug evaluation tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8005.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

